Conclusions and Implications
These results identify CBD3063, as a selective, first-in-class, CRMP2-based peptidomimetic, which allosterically regulates Cav2.2 to achieve analgesia.
Keywords: Cav2.2, CRMP2, Peptidomimetics, Molecular Dynamics Simulations, Chronic Pain.